These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2837849)

  • 21. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
    Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of cytomegalovirus infection and disease after solid-organ transplantation.
    van der Bij W; Speich R
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S32-7. PubMed ID: 11389520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
    Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy.
    Marty FM; Rubin RH
    Transpl Int; 2006 Jan; 19(1):2-11. PubMed ID: 16359371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection prophylaxis in pancreas transplant recipients.
    Stratta RJ; Taylor RJ; Sindhi R; Sudan D; Castaldo P
    Transplant Proc; 1995 Dec; 27(6):3018-9. PubMed ID: 8539820
    [No Abstract]   [Full Text] [Related]  

  • 26. [The significance of cytomegalovirus infection in the period after a heart transplant].
    Manito N; Pérez JL; Roca J; Niubó J; Gausí C; Castells E
    Rev Esp Cardiol; 1995; 48 Suppl 7():108-14. PubMed ID: 8775825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infections in bone marrow transplantation].
    Villasís-Keever A; Mosqueda JL
    Rev Invest Clin; 2005; 57(2):381-6. PubMed ID: 16524081
    [No Abstract]   [Full Text] [Related]  

  • 28. [Post-transplant infectious diseases].
    Mori T
    Rinsho Ketsueki; 2014 Oct; 55(10):2136-41. PubMed ID: 25297780
    [No Abstract]   [Full Text] [Related]  

  • 29. Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis.
    Snydman DR
    Clin Infect Dis; 2005 Mar; 40(5):709-12. PubMed ID: 15714417
    [No Abstract]   [Full Text] [Related]  

  • 30. Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.
    Fischer SA
    Transplantation; 2008 Nov; 86(10):1327-39. PubMed ID: 19033999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New guidelines are a comprehensive resource for managing infection risk among hematopoietic stem cell transplant patients.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Nov; 11(23):1-2, 5. PubMed ID: 11899981
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytomegalovirus infection and cardiac allograft vasculopathy in children.
    Webber SA
    Circulation; 2007 Apr; 115(13):1701-2. PubMed ID: 17404170
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibiotic prophylaxis in gastrointestinal surgery: an appeal for more standardized reports.
    Ivarsson LE; Darle N; Kewenter J
    Curr Surg; 1982; 39(3):149-50. PubMed ID: 7094622
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus.
    Am J Transplant; 2004 Nov; 4 Suppl 10():51-8. PubMed ID: 15504213
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
    J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infectious complications following hematopoietic stem cell transplantation].
    Akiyama H
    Rinsho Ketsueki; 2008 Aug; 49(8):576-82. PubMed ID: 18800605
    [No Abstract]   [Full Text] [Related]  

  • 39. The economic value of valacyclovir prophylaxis in transplantation.
    Squifflet JP; Legendre C
    J Infect Dis; 2002 Oct; 186 Suppl 1():S116-22. PubMed ID: 12353196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic prophylaxis of surgical infections].
    Badikov VD; Tsybuliak GN; Minnullin IP
    Vestn Khir Im I I Grek; 2002; 161(4):95-101. PubMed ID: 12577566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.